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Previous evidence indicated that discoidal reconsti-
tuted high density lipoproteins (rHDL) of apolipopro-
tein A-I (apoA-I) can interact with lipid membranes
(Tricerri, M. A., Co´rsico, B., Toledo, J. D., Garda, H. A.,
and Brenner, R. R. (1998) Biochim. Biophys. Acta 1391,
67–78). With the aim of studying this interaction, pho-
toactivable reagents and protein cleavage with CNBr
and hydroxylamine were used. The generic hydropho-
bic reagent 3-(trifluoromethyl)-3-(m-[125I]iodophenyl-
)diazirine gave information on the apoA-I regions in
contact with the lipid phase in the rHDL discs. Two
protein regions loosely bound to lipids were detected:
a C-terminal domain and a central one located be-
tween residues 87 and 112. They consist of class Y
amphipathic a-helices that have a different distribu-
tion of the charged residues in their polar faces by
comparison with class A helices, which predominate in
the rest of the apoA-I molecule. The phospholipid
analog 1-O-hexadecanoyl-2-O-[9-[[[2-[125I]iodo-4-(trif-
luoro-methyl-3-H-diazirin-3-yl)benzyl]oxy]carbonyl-
]nonanoyl]-sn-glycero-3-phosphocholine, which does
not undergo significant exchange between membranes
and lipoproteins, was used to identify the apoA-I do-
main directly involved in the interaction of rHDL discs
with membranes. By incubating either rHDL or lipid-
free apoA-I with lipid vesicles containing 125I-TID-PC,
only the 87–112 apoA-I segment becomes labeled after
photoactivation. These results indicate that the cen-
tral domain formed by two type Y helices swings away
from lipid contact in the discoidal lipoproteins and is
able to insert into membrane bilayers, a process that
may be of great importance for the mechanism of cho-
lesterol exchange between high density lipoproteins
and cell membranes.
Apolipoprotein A-I (apoA-I)1 is the major protein component
of the high density lipoproteins (HDL), which play a central
role in “reverse cholesterol transport” (1, 2). The interaction of
lipid-free apoA-I with cell membrane binding sites triggers free
cholesterol (FC) mobilization from intracellular membranes
and from cholesteryl ester stores toward the cell membrane as
a result of signals mediated by protein kinase C (reviewed in
Ref. 3). The sequential removal of phospholipids (PL) and FC
(4–7) yields lipid-poor and discoidal HDLs of pre-b electro-
phoretic migration. Discoidal pre-b HDLs, which also are se-
creted by liver, are then transformed into spherical a-migrat-
ing HDL by lecithin-cholesterol acyl transferase (LCAT), which
esterifies FC, forming a hydrophobic core of cholesteryl ester (1,
2, 6). Circulating a-HDL are modified by accepting other ap-
oproteins, such as apolipoprotein A-II, and by lipid exchange
with other serum lipoproteins (8). This lipid and apoprotein
exchange can produce lipid-free or lipid-poor apoA-I, which can
begin again the cycle of lipid removal from cells in the inter-
stitial space of peripheral tissues (6, 9). Whether the interac-
tion of apoA-I with cell membrane is mediated by a specific
receptor and the mechanism of its loading with PL and FC is
still a matter of debate (7). The recent discovery that a defective
ATP-binding cassette transporter (ABCA1) leads to Tangier
disease (10, 11) has prompted the study of the role of this
protein as a candidate apoA-I receptor (12–17). A direct molec-
ular interaction between ABCA1 and apoA-I is indicated by
some of these studies (12, 13). However, other studies (15, 16)
do not support this interaction and suggest a role for ABCA1 in
modifying the lipid distribution in the membrane and generat-
ing the biophysical microenvironment required for the docking
of apoA-I to the cell surface.
A high conformational flexibility in apoA-I is needed for its
existence in different states: lipid-free, lipid-poor, and discoidal
or spherical lipoproteins of different size. Mature human
apoA-I contains 243 amino acid residues (18) with 11- and
22-mer homologous repeats (19) that are predicted to form
amphipathic a-helices (20, 21) that interact with lipids through
their hydrophobic face. The helices are linked by short and
flexible b-turns usually containing a proline residue. Lipid-free
apoA-I is thought to be a bundle of helices (22) in a molten
globular-like state (23), and sedimentation velocity experi-
ments indicate significant conformational heterogeneity (24),
supporting a flexible structure. In the spherical a-HDL, it has
been proposed (25) that the amphipathic helices are oriented
parallel to the surface of the phospholipid monolayer with the
hydrophobic faces embedded into the hydrocarbon region and
with the hydrophilic faces interacting with the phospholipid
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polar groups and the aqueous phase. It is generally accepted
that discoidal lipoproteins are composed of a lipid bilayer disc
with the apoA-I at their edge, but the orientation of the helices
with respect to the acyl chains is controversial (see Ref. 26 for
a review; Fig. 1) The “picket fence” model (27–32) proposed
eight antiparallel amphipathic a-helices connected by b-turns
oriented parallel to the phospholipid acyl chains. However,
recent experimental evidence supports the “belt” model (33–
37), which proposes that apoA-I wraps around the edge of the
disc with the axis of its a-helices oriented perpendicular to the
acyl chains. The size of discoidal complexes is primarily deter-
mined by the number of apoA-I molecules per particle (38), but
discs with the same number of apoA-I molecules and different
amounts of lipids do also exist (39–41). A hinge domain, which
may be excluded from the interaction with lipids in small
discoidal complexes (39, 40, 42), has been proposed to be pres-
ent in the central region of apoA-I (28, 43–45) to explain the
ability of apoA-I to form different sized discoidal complexes.
The conformational flexibility of apoA-I can also play a role
in the interaction and lipid exchange of HDL with membranes.
It was hypothesized (46, 47) that the interaction of HDL discs
with membranes may involve helices of apoA-I that can swing
away from lipid contact on the disc to insert into the phospho-
lipid bilayer, thus facilitating cholesterol exchange. In spheri-
cal HDL, this apoA-I domain would be interacting with the
particle lipids and would not be able to interact with mem-
branes (47). According to this hypothesis the morphologic
change from disc to sphere or the enrichment in cholesteryl
ester would reduce the affinity of HDL particles for mem-
branes, allowing the liberation of spherical a-HDLs to the
circulation. The major problem of this hypothesis is that the
morphologic change from disc to sphere requires LCAT whose
activity is very low in lymph and interstitial fluid (48) but high
only in plasma (6). In previous reports (49, 50) we suggested, as
a possible alternative to this mechanism, that the increase in
size or in the cholesterol content in the discs could cause,
independently of LCAT activity, a conformational change in
apoA-I that decreases the affinity for membranes. Then large
cholesterol-rich discs would be liberated into circulation and
transformed into a-HDL by LCAT in plasma. This alternative
hypothesis is supported by the fact that the increase of size and
cholesterol content in the discs modifies apoA-I conformation
(45, 49) and decreases the interaction (49) and cholesterol
exchange rate (50) with lipid vesicles. The interaction of dis-
coidal complexes of apoA-I with lipid vesicles produces a tran-
sient leakage of the internal aqueous contents, which is faster
compared with the leakage produced by lipid-free apoA-I (49),
and suggests the penetration of an apoA-I domain into the
bilayer of the lipid vesicles. It was also shown that apoA-I discs
are able to interact with lipid monolayers by increasing their
lateral pressure (70). To gain further insight into the mecha-
nism of this interaction, we have used two photoactivable re-
agents to obtain information on the lipid-bound regions of
apoA-I in discoidal complexes and to identify the apoA-I region
involved in the interaction of discoidal complexes with
membranes.
EXPERIMENTAL PROCEDURES
Photoactivable Reagents—The reagents used were: 3-(trifluorom-
ethyl)-3-(m-[125I]iodophenyl)diazirine (125I-TID) and 1-O-hexadecanoyl-
2-O-(9-[[(2-[125I]iodo-4-(trifluoromethyl-3-H-diazirin-3-yl)benzyl]oxy-
]carbonyl]nonanoyl]-sn-glycero-3-phosphocholine (125I-TID-PC) (Fig. 2).
Upon photolysis, the trifluoromethyl diazirine group of these reagents
is rapidly converted to carbene, which is capable of reacting with the
full range of functional groups occurring in biomolecules, including
paraffinic carbon-hydrogen bonds (51). In membranes or lipoproteins,
the environment of carbene consists largely of acyl chains and protein
segments inserted into or in contact with the hydrophobic region of the
phospholipid. Membrane inserted domains of several proteins (52–56)
were identified by using these reagents followed by chemical or enzy-
matic cleavage. These photoreagents exhibit very different monomer
solubility in water, with one of the factors determining intermembrane
exchange/transfer rates and the spontaneous incorporation in pre-
formed membranes or lipoprotein structures (51, 52). 125I-TID is easily
incorporated into the lipid phase of preformed structures such as mem-
branes or lipoproteins with a partition coefficient highly favorable to the
lipid phase (39,000 bound ligands 3 ml external solution/free ligand 3
mg of lipids) (57). It is supposed to be uniformly distributed across the
hydrophobic region of the phospholipid bilayer, being a good candidate
for the analysis of the apoA-I regions directly in contact with the acyl
chains in discoidal complexes. On the other hand, phospholipid vesicles
containing the phospholipid analog 125I-TID-PC, which does not un-
dergo significant intermembrane transfer (51) and should locate the
active diazirine group very deep into the lipid bilayer, were used to
identify the apoA-I region able to penetrate into the vesicle bilayer.
125I-TID (10 mCi/nmol) was purchased from Amersham Pharmacia
Biotech. 125I-TID-PC was prepared by radioiodination of its nonradio-
active tin-containing precursor 1-O-hexadecanoyl-2-O- (9-[[[2-(tributyl-
stannyl)-4-(trifluoromethyl-3-H-diazirin-3-yl)benzyl]oxy]carbonyl] non-
anoyl]-sn-glycero-3-phospho-choline according to Weber and Brunner
(51). The tin precursor was generously donated by Prof. J. Brunner from
the Swiss Federal Institute of Technology (Zurich, Switzerland). The
dried tin-containing precursor (;20 nmol) was dissolved in 10 ml of
acetic acid in a 1-ml Reacti-Vial (Pierce). [125I]NaI (1 mCi) was added,
and the iodination was started by the addition of peracetic acid (2 ml of
a 32% solution in acetic acid). After 2 min at room temperature, the
reaction was quenched with 50 ml of 10% Na2S2O5. Then 40 ml of
CHCl3/methanol (2:1) was added and vortexed. The organic phase was
collected and concentrated using a charcoal filter to adsorb volatile
radioactivity. The residue was dissolved in 20 ml of methanol/CHCl3/
H2O (9:1:1) and subjected to reverse-phase high pressure liquid chro-
matography using the same solvent and a 208HS54 C8 column (Vydac)
in a Merck-Hitachi instrument with UV detection at 254 nm. The flow
rate was 1 ml/min, and fractions of 0.5 ml were collected. 125I-TID-PC
eluted at ;20 min, whereas the excess of tin-containing precursor
eluted at ;40 min. An aliquot (5 ml) of each fraction in the elution
region of 125I-TID-PC was analyzed by TLC on silica gel plates (LK6D,
60 Å; Whatman, Clifton, NJ) and subjected to autoradiography. Frac-
tions containing radioactivity were pooled and concentrated by co-
evaporation with toluene/ethanol (1:1). 125I-TID-PC was stored at
220 °C and dissolved in ethanol/toluene (1:1) at ;1 mCi/ml.
Other Materials—1-Palmitoyl-2-oleoyl-phosphatidylcholine (POPC)
was purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). Choles-
terol and sodium cholate were from Sigma. L-a-Dipalmitoyl-[2-
palmitoyl-9,10-3H(N)]-phosphatidylcholine ([3H]PC), [4-14C]cholesterol
([14C]FC), and [125I]NaI were from PerkinElmer Life Sciences.
ApoA-I Purification and Preparation of Discoidal Reconstituted High
Density Lipoproteins (rHDL)—ApoA-I was purified from the HDL frac-
tion of human serum (kindly donated by the Banco de Sangre del
Instituto de Hemoterapia de la Provincia de Buenos Aires, La Plata,
Argentina), according to the procedure previously described (58) with
some modifications (49, 50). The cholate dialysis method of Jonas et al.
(39) was used to prepare the apoA-I rHDL complexes using initial
FIG. 1. Proposed models for apoA-I structure in spherical and
discoidal HDL complexes.
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mixtures of cholate/POPC/apoA-I in the molar ratio 250/100/1 or
cholate/POPC/FC/apoA-I in the molar ratio 250/100/25/1. [3H]PC and
[14C]FC were included to allow PL and FC quantification. Differently
sized rHDL were separated by gel filtration fast protein liquid chroma-
tography (49, 50) using two columns in tandem (Superose 6 and Super-
ose 12 HR 10/30 from Amersham Pharmacia Biotech). The purity and
size of the isolated rHDL were determined by nondenaturating gradient
gel electrophoresis (41), and their composition was obtained by meas-
uring the protein content by Lowry’s method (59). PL and FC contents
were measured by scintillation counting.
Preparation of Lipid Vesicles Containing 125I-TID or 125I-TID-PC—
Large unilamellar vesicles (LUV) of POPC or POPC/FC (4/1 mol/mol)
were prepared (0.5 mM in POPC) by extrusion through polycarbonate
membranes with pore diameters of 100 nm (Avestin Inc., Otawa, Can-
ada). Lipids in CHCl3 were mixed, dried under a stream of N2, and
resuspended in 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM N3Na
(buffer A) by vortexing. Then lipid suspensions were passed 11 times
through the polycarbonate filters by using a Liposofast-extruder system
(Avestin). To incorporate 125I-TID into the LUV, 10 mCi of the photoac-
tivable reagent in ethanol were added to 0.2 ml of the LUV suspension
and incubated with stirring for at least 2 h at room temperature until
use. On the other hand, to prepare the LUV containing 125I-TID-PC
(200 mCi/mmol of POPC), the photoreagent was mixed with the lipids in
CHCl3 previous to the LUV preparation.
Photolabeling and Delipidation of ApoA-I—The photoreagent-con-
taining LUV (25 nmol of POPC) were incubated with the rHDL com-
plexes or with lipid-free apoA-I (1 nmol of apoA-I) in buffer A containing
50 mM glutathione at room temperature. After the indicated times,
mixtures (0.3 ml) in glass cuvettes were irradiated for 30 s with a Xenon
lamp (450 Watts) at a distance of 25 cm. As a control, the photoreagent-
containing LUV were also irradiated before mixing with apoA-I. 125I-
TID was directly incorporated into the rHDL complexes by adding the
reagent (1.5 mCi) in ethanolic solution to the rHDL suspension (1 nmol
of apoA-I) in buffer A with 50 mM glutathione and incubating for at least
4 h with stirring before the irradiation. After irradiation, 3 volumes of
CHCl3/methanol (2:1) were added and vortexed, and the organic phase
was discarded. ApoA-I was precipitated with 10% trichloroacetic acid
and redissolved as indicated below for chemical cleavage or in 25 ml of
sample buffer for direct analysis by SDS-polyacrylamide gel electro-
phoresis (PAGE).
Chemical Cleavage of ApoA-I with CNBr and with Hydroxylamine—
For cleavage with NH2OH, samples were dissolved and incubated at
45 °C for 4 h in 50 ml of 2 M NH2OH, 2 M urea, 0.2 M K2CO3, pH 9.0. For
cleavage with CNBr, samples were dissolved in 50 ml of 70% formic acid,
and CNBr was added in a 30:1 ratio (CNBr: protein w/w) and incubated
at 25 °C under a N2 atmosphere for 24 h. Then the samples were dried
in a Speed Vac system and redissolved in 20 ml of sample buffer for
Tricine SDS-PAGE analysis.
Analysis by SDS-PAGE and Autoradiography—SDS-PAGE was car-
ried out according to Scha¨gger and von Jagow (60) in 16.5% acrylamide
Tris-Tricine. After Coomassie Blue staining, gels were dried and ex-
posed to X-Omat film (Kodak) at 280 °C for different times depending
on the amount of radioactivity.
N-terminal Sequencing of ApoA-I Fragments—Peptide fragments
were transferred from SDS-polyacrylamide gels to polyvinylidene diflu-
oride membranes using a Trans-Blot semi-dry transfer cell (Bio-Rad).
N-terminal sequencing was performed on the bands in polyvinylidene
difluoride membranes by the Laboratorio Nacional de Investigacio´n y
Sevicio en Pe´ptidos y Proteı´nas (Universidad de Buenos Aires-Consejo
Nacional de Investigaciones Científicas y Te´cnicas, Buenos Aires, Ar-
gentina) and by the Protein Structure Core Facility, University of
Nebraska Medical Center (Omaha, NE).
RESULTS
Characterization of ApoA-I Discoidal rHDL Particles—Four
kinds of discoidal lipoprotein complexes of apoA-I were used in
this study. Two cholesterol-free (Lp2 and Lp4) and two choles-
terol-containing (Lp2C and Lp4C) rHDL complexes were puri-
fied by gel filtration fast protein liquid chromatography after
dialysis of the cholate-containing mixtures. They were pure as
judged by nondenaturating gradient gel electrophoresis. Their
size corresponded to that previously determined (49) for rHDL
containing two (85 Å Stokes diameter for Lp2 and Lp2C) or four
(150 Å for Lp4 and Lp4C) apoA-I molecules/rHDL particle. The
determined molar compositions were as follows: 57/1 and 108/1
(POPC/apoA-I) for Lp2 and Lp4 and 59/4/1 and 101/18/1
(POPC/FC/apoA-I) for Lp2C and Lp4C, respectively.
Photolabeling of ApoA-I in the Lipid-free State or as Discoi-
dal Complexes by Incubation with Lipid Vesicles Containing
125I-TID-PC—The incubation of POPC LUV containing 125I-
TID-PC with apoA-I discoidal complexes or lipid-free apoA-I
resulted in the labeling of the protein after photoactivation.
The protein cleavage with CNBr and analysis by SDS-PAGE
and autoradiography yielded the results shown in Fig. 3.
ApoA-I contains three methionine residues at which cleavage
with CNBr occurs: residues Met86, Met112, and Met148 (see Fig.
7), and only four polypeptides should be obtained by complete
cleavage. However, because of incomplete cleavage, a more
complex pattern, which can be observed in Fig. 3A, is obtained.
All of the peptide bands can be assigned as indicated in Fig. 3A
by taking into account their molecular masses and the indi-
cated N-terminal sequence. It must be noted that because of
the lower Coomassie staining sensitivity to smaller peptides,
the real cleavage extension is larger than the apparent one.
Autoradiography analysis (Fig. 3B) shows that the radioactiv-
ity is located almost exclusively (more than 90%) in the small-
est peptide band of a molecular mass similar to glucagon or the
insulin b-chain (about 3 kDa). The N-terminal sequence (Ser-
FIG. 1. Chemical structure of
125I-TID and 125I-TID-PC.
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Lys-Asp-Leu) indicates that this band corresponds to fragment
87–112. Fig. 3B (lane 8) shows that no labeling was found when
the 125I-TID-PC-containing POPC LUV were photoactivated
previously to the incubation with lipid-free apoA-I. The same
apoA-I fragment becomes almost exclusively labeled by the
incubation of these 125I-TID-PC-containing vesicles with the
different discoidal complexes (Lp2, Lp2C, Lp4, or Lp4C) or even
with lipid-free apoA-I, although a different level of labeling can
be observed, which is possibly due to differences in affinity or
the ability to interact as previously reported (49). The same
apoA-I fragment is also labeled by photoactivation of mixtures
of apoA-I discoidal complexes with POPC/FC (4/1 mol/mol)
vesicles containing the phospholipidic reagent 125I-TID-PC
(data not shown). By increasing the time of gel exposure to the
autoradiographic films (not shown), it was possible to observe
that the larger fragments that contain the 87–112 region (ami-
no acids 1–243, 1–148, 1–112, and 87–148) become also labeled,
although some unspecific label (less than 5%) is also observed
in the band corresponding to fragments 1–87 and 149–243.
These results strongly indicate that an apoA-I domain located
between residues 87 and 112 is able to penetrate the bilayer of
POPC or POPC/FC vesicles when either lipid-free apoA-I or
discoidal complexes are used.
Photolabeling of ApoA-I in Discoidal Complexes by Direct
Incubation with 125I-TID or by Incubation with Lipid Vesicles
Containing 125I-TID—Fig. 4 (lanes 1 and 2) shows that the
photoactivation of mixtures of Lp2 complexes with 125I-TID-
containing POPC/FC (4/1 mol/mol) vesicles also results in the
labeling of apoA-I. No appreciable difference in the level of
labeling is found when Lp2 complexes are preincubated for 0.5
or 5 min with the vesicles before the photoactivation. If lipid-
free apoA-I is incubated with these vesicles, the protein be-
comes also labeled but at a level that is significantly lower than
that found for the Lp2 complexes (lane 3). ApoA-I is also labeled
if 125I-TID is directly added to the Lp2 complexes (lane 5); in
this case we added only 0.5 mCi of 125I-TID to the rHDL sample
to keep the same 125I-TID/POPC ratio as in the incubation
mixtures containing Lp2 and vesicles. On the other hand, no
labeling of apoA-I is found when the 125I-TID-containing LUV
are photoactivated before their incubation with lipid-free
apoA-I (lane 6).
Samples photoactivated as in Fig. 4 were cleaved with CNBr,
and the corresponding SDS-PAGE and autoradiography anal-
yses are shown in Fig. 5. Lane 5 shows the labeling pattern
obtained by photoactivation after the direct addition of 125I-
TID to Lp2 discs. With this experimental approach, the apoA-I
regions that are in contact with the lipid bilayer of the discs
should be labeled, although it cannot be totally discarded that
some hydrophobic domains not in contact with the bilayer could
also be labeled. It is remarkable that the 87–112 fragment
(which was almost exclusively labeled by 125I-TID-PC-contain-
ing vesicles) does not become labeled by the direct addition of
125I-TID to Lp2 discs. This indicates that the 87–112 region,
although is able to penetrate into the lipid bilayer of vesicles, is
loosely bound to the disc lipid bilayer.
FIG. 3. Photolabeling of apoA-I in the lipid-free state or as
discoidal complexes by incubation with lipid vesicles contain-
ing 125I-TID-PC. POPC vesicles (25 nmol of PL) containing 5 mCi of
125I-TID-PC (V1) were incubated with 1 nmol of apoA-I as Lp2 (lane 1),
Lp2C (lane 2), Lp4 (lane 4), or Lp4C (lane 5) or in the lipid-free state (AI,
lane 6) at room temperature for 1 min and photoactivated for 30 s. As
control, 1 nmol of lipid-free apoA-I was mixed with previously photoac-
tivated 125I-TID-PC-containing vesicles (V1-pf, lane 8). After delipida-
tion, samples were cleaved with CNBr and analyzed by SDS-PAGE
with Coomassie blue staining (A) and autoradiography (B). Insulin (Ins,
lane 3), glucagon (Gln, lane 7), and nonradiolabeled apoA-I cleaved with
CNBr (AI-CNBr, lane 9) were used as standards. The assignment of the
peptide fragments produced by apoA-I cleavage by CNBr (indicated at
the left side) was made by taking into account the molecular mass and
the determined N-terminal sequence.
FIG. 4. Photolabeling of apoA-I in its lipid-free state or in
discoidal complexes Lp2 by incubation with POPC/FC (4/1) ves-
icles containing 125I-TID or by direct incubation with this pho-
toreagent. POPC/FC (4/1 mol/mol) vesicles (25 nmol of PL) containing
2.5 mCi of 125I-TID (V2-TID), were incubated with 1 nmol of apoA-I as
Lp2 for 0.5 (lane 1) and 5 (lane 2) min or with 1 nmol of lipid-free apoA-I
for 5 min (lane 3) at room temperature and photoactivated for 30 s. 1
nmol of apoA-I as Lp2 was also incubated directly with 0.5 mCi of
125I-TID for 8 h at room temperature and photoactivated for 30 s
(Lp2 1 TID, lane 5). As a control, 1 nmol of lipid-free apoA-I was also
mixed with previously photoactivated 125I-TID-containing vesicles (AI
1 V1-TID-pf, lane 6). After delipidation, the samples were analyzed by
SDS-PAGE with Coomassie Blue staining (A) and autoradiography (B).
Nonradiolabeled apoA-I (AI Std, lane 4) was used as standard.
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The incubation of Lp2 discs with 125I-TID-containing vesicles
during a short period of time (30 s) before the photoactivation,
results in a detectable labeling of the 87–112 fragment (lane 2).
However, if the preincubation time is extended up to 5 min
(lane 3), the label in the 87–112 fragment is no longer detected,
and a similar labeling pattern to that obtained by the direct
addition of the reagent to the discs is obtained. These results
indicate that 125I-TID, as expected from its higher monomer
solubility in water and its intermembrane exchange/transfer
rate as compared with 125I-TID-PC (51), diffuses rapidly from
the lipid bilayer of the vesicles toward the bilayer of the discs,
where it should label the apoA-I regions in contact with the disc
lipids. Only at a short time after mixing the 125I-TID-contain-
ing vesicles with the rHDL discs should the reagent concentra-
tion in the vesicles be high enough to produce a detectable
labeling of the 87–112 apoA-I region. With the time course after
mixing, the reagent concentration decreases in the vesicles and
increases in the discs until the equilibrium is reached. By
assuming a similar partition of 125I-TID between both vesicle
and disc lipid bilayer, it can be calculated that in the conditions
used here, the reagent concentration in the vesicles would
decrease at the equilibrium more than 3- or 5-fold when incu-
bated with Lp2 or Lp4, respectively. Moreover, it must be also
considered that at any time, only a small proportion of the discs
(depending on the membrane affinity of each kind of rHDL
disc) are interacting with vesicles through the 87–112 apoA-I
region, whereas most of the discs would be free and thus with
the apoA-I 87–112 region unaccessible to be labeled by the
reagent located in the vesicles. On the contrary, 100% of the
apoA-I molecules are interacting with the disc lipid bilayer and
thus are accessible to be labeled in their contact regions by the
reagent located there. This fact makes difficult the detection of
label in the membrane inserted domain when a significant
amount of reagent is transferred from the vesicles toward the
disc bilayer.
Even by using a short incubation time before the photoacti-
vation, no detectable labeling of the 87–112 fragment was
observed when 125I-TID-containing vesicles were incubated
with large (Lp4) or FC-containing (Lp2C or Lp4C) rHDL discs
(Fig. 5, lanes 7–9). Because the 87–112 fragment was labeled
when these discs were incubated with vesicles containing the
nondiffusible reagent 125I-TID-PC (Fig. 3), it must be concluded
that these large and FC-containing discs interact with vesicles
in a way similar to that of Lp2 through the membrane insertion
of a central domain in the 87–112 region. The lack of labeling of
this apoA-I region by 125I-TID-containing vesicles in Lp2C,
Lp4, and Lp4C is very likely to be due to their lower ability to
interact with lipid membranes in comparison with Lp2, as it
was previously shown (49).
Although 125I-TID was not useful in detecting the membrane
inserted domain, because of its higher intermembrane transfer
rate, it was very helpful to detect the apoA-I regions loosely
bound to the disc lipid bilayer. Incomplete CNBr cleavage of
apoA-I allows us to conclude that, in addition to the central
87–112 region, a C-terminal apoA-I domain is also not in con-
tact with the lipid bilayer of discoidal complexes. As already
mentioned the complete cleavage should produce four peptides:
1–86, 87–112, 113–148, and 149–243. In contrast to the 87–
112 fragment, the 113–148 peptide becomes labeled by the
125I-TID, and it should be in contact with the lipid bilayer of the
discs (Fig. 5). The N- and C-terminal fragments 1–86 and
149–243 co-migrate on SDS-PAGE, giving a unique band that
contains a high level of radioactivity. Co-migration of these
peptides does not allow us to conclude whether both or only one
of them becomes labeled. However, the radioactivity distribu-
tion in peptides 1–112 and 113–243, which are produced by
incomplete cleavage, indicates that the C-terminal region be-
comes labeled at a very low level. Fragment 1–112 contains a
higher level of radioactivity than the 113–243 fragment, de-
spite its lower mass as indicated by the intensity of Coomassie
staining. Moreover, fragment 1–112 contains the 87–112 re-
gion, which is not labeled, and fragment 113–243 contains the
113–148 region, which is labeled. For all of these reasons we
conclude that the C-terminal region of apoA-I is poorly labeled
and that it should be loosely bound to the lipid bilayer of discs.
To confirm this, a second cleavage strategy was used. Hydrox-
ylamine cleaves apoA-I at its unique Asn184–Gly185 bond (Fig.
6), giving a large N-terminal polypeptide (1–184) and a shorter
C-terminal fragment (185–243) as can be observed in Fig. 6A.
Autoradiography shows that only the large 1–184 fragment
becomes labeled by photoactivation of mixtures of Lp2 or lipid-
free apoA-I with vesicles containing 125I-TID (Fig. 6B). No
FIG. 5. Chemical cleavage with
CNBr of apoA-I photolabeled with
125I-TID. Samples treated as in Fig. 4
were delipidated, digested with CNBr,
and analyzed by SDS-PAGE with Coo-
massie Blue staining (A) and autoradiog-
raphy (B). Lane 1, insulin standard (Ins).
Lanes 2 and 3, Lp2 incubated for 0.5 and
5 min respectively with 125I-TID-contain-
ing POPC/FC vesicles (V2). Lane 4, lipid-
free apoA-I incubated for 5 min with the
same vesicles. Lane 5, Lp2 incubated di-
rectly with 125I-TID. Lane 6, nonradiola-
beled apoA-I digested with CNBr. Lanes
7, 8, and 9, Lp2C, Lp4, and Lp4C respec-
tively, incubated for 0.5 min with V2
vesicles.
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appreciable radioactivity was found in the shorter C-terminal
185–243 fragment, indicating that this apoA-I region has a low
contact with the lipid bilayer of the discs.
DISCUSSION
The results obtained with the 125I-TID reagent indicate that
two apoA-I regions have little if any contact with the lipid
bilayer of the discoidal lipoprotein complexes: a C-terminal
region and a central one located between the residues 87–112.
Fig. 7 shows the amino acid sequence of apoA-I and the am-
phipathic a-helices, which are predicted to be present in this
protein (21, 25, 26). Segrest and colleagues (21) and others (15)
proposed that the a-helices of apolipoproteins are not all equiv-
alent in their affinities toward lipids. The differences in affinity
do not appear to be only related to their hydrophobic moment
but also to the distribution of charged residues along the axis of
the helix. Amphipathic helices are classified into seven major
and distinct classes (A, H, L, G, K, C, and M) based upon a
detailed analysis of their physico-chemical and structural prop-
erties (21). The most frequent helix class found in exchangeable
apolipoproteins is class A, which is characterized by a unique
clustering of positively charged amino acid residues at the
polar-nonpolar interface and negatively charged residues at
the center of the polar face. As shown in Fig. 7, six class A
helices have been identified in apoA-I (25, 26): helices 44–65,
66–87, 121–142, 143–164, 166–186, and 187–208. In addition,
two other helix types were also identified: class G* (helix 8–33)
and class Y (helices 88–98, 99–120, 209–219, and 220–241).
Class G* helices are distinguished by a random radial arrange-
ment of positive and negative residues, which is similar but not
identical to that of the class G helices found in globular pro-
teins. The basic features of the class Y motif are two negative
residue clusters on the polar face separating the two arms and
the base of the Y motif formed by three positive residue clusters
(25). Interestingly, the two apoA-I regions not labeled with
125I-TID, indicating little contact with the lipid bilayer of dis-
coidal complexes, are rich in the class Y motif. In both regions,
a short helix of 10–11 residues is followed by a long one of 21
residues. This fact would agree with the hypothesis that lipid
affinity correlates with the extent to which a helix domain fits
to class A motif (25, 61). However, a synthetic peptide contain-
ing the 220–241 apoA-I has been shown to have the highest
affinity toward lipids among the other apoA-I helices (62).
These discrepancies could be due to different affinity toward
the edge of a lipid bilayer disc compared with the affinity
toward the surface monolayer of vesicles or spherical particles
and due to the fact that other factors such as interhelix inter-
actions are playing an important role.
The central region 87–112, although loosely bound to the
lipids of the discoidal complexes, is able to penetrate the bilayer
of lipid vesicles as indicated by the results obtained with the
125I-TID-PC reagent. It is remarkable that the same 87–112
segment of apoA-I becomes labeled when 125I-TID-PC-contain-
ing vesicles are mixed either with discoidal complexes or with
lipid-free apoA-I. This fact suggests that apoA-I could be liber-
ated from the discs and that it then could interact with the
vesicle bilayer as lipid-free apoA-I. This possibility, however, is
not likely because it was shown (49) that discoidal complexes
induce leakage of the vesicle internal aqueous space much
faster than lipid-free apoA-I. Also, the lateral pressure increase
in lipid monolayers occurs more rapidly with discoidal com-
plexes than with lipid-free apoA-I (70).
The interaction between apoA-I discs and lipid vesicles re-
sults also in resonance energy transfer from tryptophan fluo-
rescence to a nonexchangeable fluorescent phospholipid (diphe-
nylhexatrienyl-phosphatidylcholine) in the vesicles (70).
However, tryptophan fluorescence is not quenched when the
vesicles contain phospholipid analogs (doxyl-phosphatidylcho-
lines) having a collisional quencher group in different posi-
tions.2 These observations indicate that no tryptophan residue
of apoA-I penetrates the lipid bilayer of the vesicles so that it
could be quenched by collision with doxyl-phosphatidylcho-
lines, although at least one tryptophan residue would lie at a
distance short enough to produce an energy transfer to the
fluorescent phospholipid. The 87–112 apoA-I fragment that
becomes labeled with 125I-TID-PC contains a tryptophan resi-
due at the 108 position. This residue would not be inserted into
the bilayer of the lipid vesicles but would be located very near
the interface, so that it would be responsible for the resonance
energy transfer to the fluorescent phospholipid.
Fig. 8 shows the Edmundson wheel representation of the
type Y amphipathic a-helices of this apoA-I segment. It con-
tains the short 88–98 helix and the first half (99–112) of the
long 99–120 helix. Because the hydrophobic faces of these
helices are narrower than the hydrophilic ones, an interaction
between both helices through their hydrophobic faces would
expose only the hydrophilic residues, so that this domain could
avoid contact with the lipid bilayer in the discoidal complexes,
independently of which model is considered. To penetrate the
membrane bilayer, rotation of the helices should occur to ex-
pose the nonpolar residues to the hydrophobic lipid phase en-
vironment. There are at least two possibilities for the mem-
brane penetration by amphipathic helices (Fig. 9): (a) a vertical
penetration with the helix axis parallel to the hydrocarbon
phospholipid chains, which would require two or more helices
interacting through their hydrophilic faces to expose the hy-
drophobic faces to the lipid environment, and b) a horizontal
interaction with the helix axis parallel to the membrane sur-
face, which requires the insertion of the nonpolar face into the
2 J. D. Toledo and H. A. Garda, unpublished results.
FIG. 6. Chemical cleavage with hydroxylamine of apoA-I pho-
tolabeled with 125I-TID. Samples treated as in described in the leg-
ends of Figs. 3 and 4 were delipidated, digested with hydroxylamine,
and analyzed by SDS-PAGE with Coomassie Blue staining (A) and
autoradiography (B). Lane 1, insulin standard (Ins). Lanes 2 and 3, Lp2
incubated for 0.5 and 5 min, respectively, with 125I-TID-containing
POPC/FC vesicles Lane 4, lipid-free apoA-I incubated for 5 min with the
same vesicles. Lane 5, Lp2 incubated directly with 125I-TID. Lane 6,
nonradiolabeled apoA-I digested with hydroxylamine (AI-NH2OH).
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hydrophobic interior of the external phospholipid monolayer;
the hydrophilic face remains exposed to the aqueous phase
and/or interacts with the phospholipid polar groups.
The vertical membrane penetration of only these two helices
interacting by their polar faces seems to be very unlikely.
Although the charged residue distribution at both sides of
proline 99 would make the interaction possible through salt
bridges between both helices, the hydrophilic faces are too
wide, a fact that would result in the exposure of polar residues
to the lipid environment. Moreover, this would require a large
conformational change because a 180° rotation of each helix is
needed to switch from the lipid-unbound state in the discoidal
complexes to the membrane inserted state. Another possibility
is suggested by the analogy found with the three-dimensional
PSSM program (63) of this apoA-I central region with ectato-
min. This is a toxic peptide of 7.9 kDa that inserts into cellular
and artificial membranes to form ionic channels (64, 65) and
whose spatial structure in aqueous solution was resolved by 1H
NMR (66). Ectotamin contains two homologous polypeptide
chains (37 and 34 residues) of similar conformation linked by
disulfide bridges. Each chain consists of two a-helices and a
hinge region of four residues giving an overall structure of a
four-helix bundle (66). On insertion into artificial membrane
bilayers, two ectatomin molecules rearrange with considerable
movement of their helical parts (64) to form an ion pore. Thus,
it should be possible for the two helices of the 87–112 region of
apoA-I to interact with the same region of another apoA-I
molecule to vertically penetrate the vesicle bilayer in a way
similar to ectatomin. As recently determined (37), positions 132
of each apoA-I monomer in Lp2 discs are in close proximity,
suggesting the possibility that the 87–112 regions are also near
each other. Moreover, it is also possible that central domains of
apoA-I molecules belonging to different discoidal particles can
interact in a way similar to that of ectatomin to be inserted into
membranes. Other possibility to be considered is that helix
FIG. 7. Amino acid sequence and
amphipathic a-helices in apolipopro-
tein A-I. Amino acid residues in pre-
dicted amphipathic helices (from residue
15) are highlighted: class G* helix (8–33)
is marked in black, class A helices (44–
65, 67–87, 122–142, 144–164, 166–186,
and 187–208) are in light gray, and class
Y helices (88–98, 100–120, 209–219, and
221–241) are in dark gray. The three sites
for cleavage with CNBr (/), the unique site
for cleavage with hydroxylamine (u), and
the 87–112 region that is labeled with
125I-TID-PC (double underlined) are also
indicated.
FIG. 8. Edmunson wheel diagram of the class Y amphipathic
a-helices in the central apoA-I domain. Helix 86–98 and the first
part (101–113) of the 99–120 helix are represented as antiparallel
helices interacting through their hydrophobic faces (A) or exposing
these faces (B) to interact with lipids. Hydrophobic, positive, negative,
and neutral amino acid residues are shown with circles, triangles,
inverted triangles, and squares, respectively. Viewed from top, the first
(solid black line), second (solid dark gray line), third (solid light gray
line), and fourth (dashed light gray line) helix turns are distinguished.
Proline 99 and tyrosine 100 residues are shown out of the helical
regions linked by a dotted black line.
FIG. 9. Two possible models for the membrane insertion of the
central apoA-I domain located in the 87–1123 region. A, vertical
insertion. B, horizontal insertion.
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content could change during the membrane insertion of the
central domain. Although the crystal structure of an apoA-I
fragment lacking the 43 N-terminal amino acids confirmed that
the 87–112 region has a helical conformation (33), the helical
content has shown to change among the lipid-free and different
lipid-bound states (23, 39, 40, 67)
Although more experimental evidence would be required to
determine how this central apoA-I domain is inserted into the
bilayer of lipid vesicles, the horizontal insertion parallel to the
membrane surface seems to be more likely. This type of inter-
action was postulated for apolipoprotein insertion into the sur-
face phospholipid monolayer of spherical lipoproteins (25, 61),
and it is known as the “snorkel” model.
From the reports of Segrest et al. (25) and Palgunachari et al.
(62), a relatively low affinity for the membrane bilayer of the
87–112 region of apoA-I could be expected. Cholesterol ex-
change between HDL and membranes or other lipoproteins can
occur by free diffusion through the aqueous medium (68, 69),
but there is also evidence (47, 50) that it can be facilitated by
the binding of HDL to membranes. The low affinity of the
central apoA-I domain in the 87–112 region could be important
for the functional need of a reversible and transient anchoring
of HDL discs to cell membranes.
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